Punch and Associates sends letter to Board of Directors of Avid Bioservices, Inc.
MINNEAPOLIS--Punch & Associates intends to vote AGAINST proposed acquisition of Avid Bioservices, Inc. by GHO Capital and Ampersand Capital.
Zacks.com on MSN12h
Bluebird Bio (BLUE) Reports Q3 Loss, Lags Revenue Estimates
Bluebird Bio (BLUE) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to loss of $0.66 per share a year ago. These figures are ...